| 1 | [SID103176474] | Active | IC50 | 28.6 | Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy [AID386625, Type: Literature] | Solute carrier family 22 member 1 [gi:313104181] |   View X | Row No. | 1 | | Structure | 
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Active | | IC50 | 28.6 [uM] | | BioAssay | Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy | | AID | 386625 | | BioAssay type | Literature | | Target | Solute carrier family 22 member 1 [gi:313104181] | | PubMed | 18788725 | | Data Table | |
|
| 2 | [SID85220236] | Active | | | Ligands of bioamine (Class A) GPCRs [AID2062, Type: other] | | View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85220236 | | CID | 4631 | | Outcome | Active | | BioAssay | Ligands of bioamine (Class A) GPCRs | | AID | 2062 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 3 | [SID85788907] | Active | | | Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells [AID2275, Type: screening] | | View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85788907 | | CID | 4631 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells | | AID | 2275 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table | |
|
| 4 | [SID103176474] | Active | | | Unbound drug concentration in Sprague-Dawley rat plasma administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method [AID604020, Type: Literature] | | View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Active | | BioAssay | Unbound drug concentration in Sprague-Dawley rat plasma administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method | | AID | 604020 | | BioAssay type | Literature | | Target | | | PubMed | 19764786 | | Data Table | |
|
| 5 | [SID103176474] | Unspecified | | | Unbound volume of distribution in Sprague-Dawley rat brain measured per gram of brain tissue administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method [AID604021, Type: Literature] | | View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Unbound volume of distribution in Sprague-Dawley rat brain measured per gram of brain tissue administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method | | AID | 604021 | | BioAssay type | Literature | | Target | | | PubMed | 19764786 | | Data Table | |
|
| 6 | [SID103176474] | Unspecified | | | Fraction unbound in Sprague-Dawley rat plasma administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method [AID604022, Type: Literature] | | View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Fraction unbound in Sprague-Dawley rat plasma administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method | | AID | 604022 | | BioAssay type | Literature | | Target | | | PubMed | 19764786 | | Data Table | |
|
| 7 | [SID103176474] | Unspecified | | | Ratio of total drug level in brain to plasma in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method [AID604023, Type: Literature] | | View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Ratio of total drug level in brain to plasma in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method | | AID | 604023 | | BioAssay type | Literature | | Target | | | PubMed | 19764786 | | Data Table | |
|
| 8 | [SID103176474] | Unspecified | | | Human intestinal absorption in po dosed human [AID476929, Type: Literature] | | View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Human intestinal absorption in po dosed human | | AID | 476929 | | BioAssay type | Literature | | Target | | | PubMed | 20022146 | | Data Table | |
|
| 9 | [SID103176474] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature] | | View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans | | AID | 588211 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table | |
|
| 10 | [SID103176474] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents [AID588212, Type: Literature] | | View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents | | AID | 588212 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table | |
|
| 11 | [SID103176474] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents [AID588213, Type: Literature] | | View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents | | AID | 588213 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table | |
|
| 12 | [SID103176474] | Unspecified | | | Apparent permeability across human Caco2 cell membrane after 2 hrs by LC-MS/MS analysis [AID592681, Type: Literature] | | View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Apparent permeability across human Caco2 cell membrane after 2 hrs by LC-MS/MS analysis | | AID | 592681 | | BioAssay type | Literature | | Target | | | PubMed | 21458999 | | Data Table | |
|
| 13 | [SID103176474] | Unspecified | | | In-vivo blood/plasma to lung partition coefficients of the compound, logP(lung) in rat [AID603954, Type: Literature] | | View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | In-vivo blood/plasma to lung partition coefficients of the compound, logP(lung) in rat | | AID | 603954 | | BioAssay type | Literature | | Target | | | PubMed | 17544548 | | Data Table | |
|
| 14 | [SID103176474] | Unspecified | | | Unbound brain to plasma concentration ratio in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr [AID604024, Type: Literature] | | View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Unbound brain to plasma concentration ratio in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr | | AID | 604024 | | BioAssay type | Literature | | Target | | | PubMed | 19764786 | | Data Table | |
|
| 15 | [SID103176474] | Unspecified | | | Unbound CSF to plasma concentration ratio in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method [AID604025, Type: Literature] | | View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Unbound CSF to plasma concentration ratio in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method | | AID | 604025 | | BioAssay type | Literature | | Target | | | PubMed | 19764786 | | Data Table | |
|
| 16 | [SID103176474] | Unspecified | | | In vivo beta-adrenoreceptor blocking potency in cat (expressed as total dose infused over a period of 30 minutes causing 50% inhibition of the tachycardia by iv administration) [AID48524, Type: Literature] | | View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | In vivo beta-adrenoreceptor blocking potency in cat (expressed as total dose infused over a period of 30 minutes causing 50% inhibition of the tachycardia by iv administration) | | AID | 48524 | | BioAssay type | Literature | | Target | | | PubMed | 6106716 | | Data Table | |
|
| 17 | [SID103176474] | Unspecified | | | Beta-adrenoreceptor blocking potency in cat, measured as the degree (percent) of blockade of the vasodepressor response at the dose level [AID48526, Type: Literature] | | View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Beta-adrenoreceptor blocking potency in cat, measured as the degree (percent) of blockade of the vasodepressor response at the dose level | | AID | 48526 | | BioAssay type | Literature | | Target | | | PubMed | 6106716 | | Data Table | |
|
| 18 | [SID103176474] | Unspecified | | | Percent inhibition of vasorepressor response [AID48537, Type: Literature] | | View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Percent inhibition of vasorepressor response | | AID | 48537 | | BioAssay type | Literature | | Target | | | PubMed | 6118435 | | Data Table | |
|
| 19 | [SID103176474] | Unspecified | | | Permeability across human Caco-2 cells [AID455986, Type: Literature] | | View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Permeability across human Caco-2 cells | | AID | 455986 | | BioAssay type | Literature | | Target | | | PubMed | 19734051 | | Data Table | |
|
| 20 | [SID103176474] | Unspecified | | | Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement [AID4411, Type: Literature] | | View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement | | AID | 4411 | | BioAssay type | Literature | | Target | | | PubMed | 8568799 | | Data Table | |
|
| 21 | [SID103176474] | Unspecified | | | Partition coefficient (logP) [AID23471, Type: Literature] | | View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) | | AID | 23471 | | BioAssay type | Literature | | Target | | | PubMed | 6145802 | | Data Table | |
|
| 22 | [SID103176474] | Unspecified | | | pK value is evaluated [AID25049, Type: Literature] | | View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | pK value is evaluated | | AID | 25049 | | BioAssay type | Literature | | Target | | | PubMed | 6145802 | | Data Table | |
|
| 23 | [SID103176474] | Unspecified | | | Dissociation constant of the compound [AID25572, Type: Literature] | | View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Dissociation constant of the compound | | AID | 25572 | | BioAssay type | Literature | | Target | | | PubMed | 9876108 | | Data Table | |
|
| 24 | [SID103176474] | Unspecified | | | Distribution coefficient measured in Octanol/buffer (0.15 M KCl) [AID26525, Type: Literature] | | View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Distribution coefficient measured in Octanol/buffer (0.15 M KCl) | | AID | 26525 | | BioAssay type | Literature | | Target | | | PubMed | 9876108 | | Data Table | |
|
| 25 | [SID103176474] | Unspecified | | | Delta logD (logD6.5 - logD7.4) [AID27167, Type: Literature] | | View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Delta logD (logD6.5 - logD7.4) | | AID | 27167 | | BioAssay type | Literature | | Target | | | PubMed | 10891117 | | Data Table | |
|
| 26 | [SID103176474] | Unspecified | | | Apparent permeability coefficient (Papp) (Caco-2 cell monolayer) [AID28392, Type: Literature] | | View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Apparent permeability coefficient (Papp) (Caco-2 cell monolayer) | | AID | 28392 | | BioAssay type | Literature | | Target | | | PubMed | 11384238 | | Data Table | |
|
| 27 | [SID103176474] | Unspecified | | | Cellular permeability (Pc) (Caco-2 cell monolayer) [AID28399, Type: Literature] | | View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Cellular permeability (Pc) (Caco-2 cell monolayer) | | AID | 28399 | | BioAssay type | Literature | | Target | | | PubMed | 11384238 | | Data Table | |
|
| 28 | [SID103176474] | Unspecified | | | Partition coefficient (logD6.5) [AID28681, Type: other] | | View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logD6.5) | | AID | 28681 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 29 | [SID103176474] | Unspecified | | | Ionization constant (pKa) [AID29359, Type: other] | | View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Ionization constant (pKa) | | AID | 29359 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 30 | [SID103176474] | Unspecified | | | Oral bioavailability in human [AID29812, Type: Literature] | | View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Oral bioavailability in human | | AID | 29812 | | BioAssay type | Literature | | Target | | | PubMed | 10891117 | | Data Table | |
|
| 31 | [SID103176474] | Unspecified | | | Fraction absorbed after oral administration in humans [AID29844, Type: Literature] | | View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Fraction absorbed after oral administration in humans | | AID | 29844 | | BioAssay type | Literature | | Target | | | PubMed | 11384238 | | Data Table | |
|
| 32 | [SID103176474] | Unspecified | | | Estimation of fraction absorbed (Fa) in the human intestine using biosensor technology. [AID29845, Type: Literature] | | View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Estimation of fraction absorbed (Fa) in the human intestine using biosensor technology. | | AID | 29845 | | BioAssay type | Literature | | Target | | | PubMed | 10841786 | | Data Table | |
|
| 33 | [SID103176474] | Unspecified | | | Beta-blocking activity was measured by applying the stepwise linear discriminate analysis; Active [AID41895, Type: other] | | View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Beta-blocking activity was measured by applying the stepwise linear discriminate analysis; Active | | AID | 41895 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 34 | [SID103176474] | Unspecified | | | Beta adrenoceptor blocking potency was estimated by inhibition of 50% of the tachycardia produced by a submaximal dose of the isoproterenol (0.2ug/kg, intravenously) [AID41903, Type: Literature] | | View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Beta adrenoceptor blocking potency was estimated by inhibition of 50% of the tachycardia produced by a submaximal dose of the isoproterenol (0.2ug/kg, intravenously) | | AID | 41903 | | BioAssay type | Literature | | Target | | | PubMed | 6118435 | | Data Table | |
|
| 35 | [SID103176474] | Unspecified | | | Beta-1-adrenoreceptor antagonsim of compound expressed as inhibition of isoprenaline-induced tachycardia in the ganglion-blocked anesthetized cat [AID48346, Type: Literature] | | View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Beta-1-adrenoreceptor antagonsim of compound expressed as inhibition of isoprenaline-induced tachycardia in the ganglion-blocked anesthetized cat | | AID | 48346 | | BioAssay type | Literature | | Target | | | PubMed | 2892934 | | Data Table | |
|
| 36 | [SID103176474] | Unspecified | | | Percent of the drug absorbed after administration to humans was determined [AID15120, Type: Literature] | | View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Percent of the drug absorbed after administration to humans was determined | | AID | 15120 | | BioAssay type | Literature | | Target | | | PubMed | 10346926 | | Data Table | |
|
| 37 | [SID103176474] | Unspecified | | | Percent of drug absorbed by human intestine after oral administration [AID18847, Type: Literature] | | View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Percent of drug absorbed by human intestine after oral administration | | AID | 18847 | | BioAssay type | Literature | | Target | | | PubMed | 11020286 | | Data Table | |
|
| 38 | [SID103176474] | Unspecified | | | Mono layer permeability of human intestinal Caco-2 cells [AID21254, Type: Literature] | | View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Mono layer permeability of human intestinal Caco-2 cells | | AID | 21254 | | BioAssay type | Literature | | Target | | | PubMed | 9876108 | | Data Table | |
|
| 39 | [SID103176474] | Unspecified | | | Intrinsic Sympathomimetic Activity (ISA) determined from the ratio of the maximal compound and isoprenaline induced tachycardia in anesthetized ganglion blocked cats following intravenous administration [AID48368, Type: Literature] | | View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Intrinsic Sympathomimetic Activity (ISA) determined from the ratio of the maximal compound and isoprenaline induced tachycardia in anesthetized ganglion blocked cats following intravenous administration | | AID | 48368 | | BioAssay type | Literature | | Target | | | PubMed | 2892934 | | Data Table | |
|
| 40 | [SID103176474] | Unspecified | | | Beta-adrenoreceptor blocking potency in the isolated guinea pig heart, giving 50% inhibition of isoproterenol-induced tachycardia [AID78651, Type: Literature] | | View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Beta-adrenoreceptor blocking potency in the isolated guinea pig heart, giving 50% inhibition of isoproterenol-induced tachycardia | | AID | 78651 | | BioAssay type | Literature | | Target | | | PubMed | 6145802 | | Data Table | |
|
| 41 | [SID103176474] | Unspecified | | | Beta-adrenoreceptor blocking potency in the isolated guinea pig heart, giving 50% inhibition of isoproterenol-induced tachycardia relative to oxprenolol [AID78664, Type: Literature] | | View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Beta-adrenoreceptor blocking potency in the isolated guinea pig heart, giving 50% inhibition of isoproterenol-induced tachycardia relative to oxprenolol | | AID | 78664 | | BioAssay type | Literature | | Target | | | PubMed | 6145802 | | Data Table | |
|
| 42 | [SID103176474] | Unspecified | | | Binding constant against human serum albumin (HSA) [AID91481, Type: Literature] | | View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Binding constant against human serum albumin (HSA) | | AID | 91481 | | BioAssay type | Literature | | Target | | | PubMed | 11728183 | | Data Table | |
|
| 43 | [SID103176474] | Unspecified | | | Binding to POPC (palmitoyl-oleolyl-phosphatidyl-choline) liposomes using biosensor system [AID156202, Type: Literature] | | View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Binding to POPC (palmitoyl-oleolyl-phosphatidyl-choline) liposomes using biosensor system | | AID | 156202 | | BioAssay type | Literature | | Target | | | PubMed | 10841786 | | Data Table | |
|
| 44 | [SID103176474] | Unspecified | | | Binding to POPC/GMI liposomes using biosensor system [AID156204, Type: Literature] | | View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Binding to POPC/GMI liposomes using biosensor system | | AID | 156204 | | BioAssay type | Literature | | Target | | | PubMed | 10841786 | | Data Table | |
|
| 45 | [SID103176474] | Unspecified | | | Ratio of [(apical to basal)/(basal to apical)] (Caco-2 cell monolayer) [AID231333, Type: Literature] | | View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Ratio of [(apical to basal)/(basal to apical)] (Caco-2 cell monolayer) | | AID | 231333 | | BioAssay type | Literature | | Target | | | PubMed | 11384238 | | Data Table | |
|
| 46 | [SID103176474] | Unspecified | | | Tested for fraction of oral dose absorbed orally in humans [AID237585, Type: Literature] | | View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Tested for fraction of oral dose absorbed orally in humans | | AID | 237585 | | BioAssay type | Literature | | Target | | | PubMed | 15857133 | | Data Table | |
|
| 47 | [SID103176474] | Unspecified | | | Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA [AID288184, Type: Literature] | | View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA | | AID | 288184 | | BioAssay type | Literature | | Target | | | PubMed | 17418579 | | Data Table | |
|
| 48 | [SID103176474] | Unspecified | | | Permeability coefficient through artificial membrane in presence of stirred water layer [AID288185, Type: Literature] | | View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Permeability coefficient through artificial membrane in presence of stirred water layer | | AID | 288185 | | BioAssay type | Literature | | Target | | | PubMed | 17418579 | | Data Table | |
|
| 49 | [SID103176474] | Unspecified | | | Partition coefficient, log P of the compound [AID288192, Type: Literature] | | View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Partition coefficient, log P of the compound | | AID | 288192 | | BioAssay type | Literature | | Target | | | PubMed | 17418579 | | Data Table | |
|
| 50 | [SID103176474] | Unspecified | | | Permeability coefficient in human skin [AID311367, Type: Literature] | | View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103176474 | | CID | 4631 | | Outcome | Unspecified | | BioAssay | Permeability coefficient in human skin | | AID | 311367 | | BioAssay type | Literature | | Target | | | PubMed | 17827020 | | Data Table | |
|
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
